Moreover, both androgens and estrogens are hypothesized to prevent tumor growth in part by preventing insulin and insulin-like growth factor (IGF) from binding to their receptors [63] and there is evidence of an association between IGF-1 and the risk of CRC [64]. Here, IGF1 is linked to neoplasm.